Navigation Links
EtQ’s Chief Technology Officer to Speak at INTERPHEX

Farmingdale, NY (PRWEB) April 16, 2013

EtQ is pleased to announce that its CTO, Morgan Palmer, will be speaking at INTERPHEX, to be held from April 23st to 25th in New York, NY.

Palmer will present the topic, “Establishing a Quality Agreement with a Unified Approach for all Suppliers,” at 10:15 am on Wednesday, April 24th.

“It is important to understand the various elements that can arise as a result of poor supply chain quality,” stated Palmer. “This session will explain these elements and will discuss the benefits of extending the quality system to suppliers, such as real-time risk management in the supply chain. Ultimately, what attendees will take away from this session is an understanding of the need for harmonizing quality agreements for suppliers as well as the best practices in extending the quality system to the supply chain.”

EtQ will also be exhibiting at INTERPHEX. For more information, visit us in booth 1861, or on the Web at In addition, EtQ is offering a 50 percent discount on conference registration. Register here to receive this discount on either one- or two-day conference packages. This will provide access to all INTERPHEX Conference sessions including keynotes, technical workshops, special Thursday presentations, lunch on Tuesday and/or Wednesday as well as access to the show floor.

INTERPHEX is the leading annual pharmaceutical and biopharmaceutical trade show. Key decision makers find the networking opportunities, products, services and information they need to ensure quality and maximize efficiency, agility, and flexibility that solve manufacturing and supply chain problems. INTERPHEX is where intelligence and passion intersect with the full spectrum of industry products and services to create new insights and innovation.

About EtQ
EtQ is the leading FDA Compliance, Quality, EHS, and Operational Risk Management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. Founded in 1992, EtQ has always had a unique knowledge of FDA Compliance, Quality, EHS, and Operational Risk processes, and strives to make overall quality operations and management systems better for businesses. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona. EtQ has been providing software solutions to a variety of markets for more than 20 years. For more information, please visit or contact us at 800-354-4476.

EtQ is a trademark of EtQ Management Consultants, Inc. All other product names and company names are trademarks or registered trademarks of their respective owners.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
2. PI hires William Culpi as Engineering Chief - PI miCos USA Products by PI USA
3. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
4. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
5. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
6. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
7. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
8. Janet Kreizman Appointed Chief Executive Officer of AACC
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
11. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):